The New Market Segmentation – Increasing Treatment Duration Through Market Interventions

Posted by: Craig Radley on 2/6/2019

We’ve all heard the business adage that acquiring a new customer costs 6 – 7 times as much as retaining an existing one. But how often is that wisdom applied for pharmaceutical products? As an industry, we are often too focused on driving new patient prescriptions and forget to focus on the patients already taking our product. Average treatment duration is one of the most important metrics in evaluating sales of a pharmaceutical product and small improvements translate directly to a product’s bottom-line. Read the full post to learn more!

Read Full Post

Tags: Segmentation | Treatment Duration | Pharmaceuticals
Related Posts: Fall 2018